CRYSELLE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cryselle, and when can generic versions of Cryselle launch?
Cryselle is a drug marketed by Duramed Pharms Barr and is included in one NDA.
The generic ingredient in CRYSELLE is ethinyl estradiol; norgestrel. There are twenty-six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norgestrel profile page.
Summary for CRYSELLE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 5 |
Patent Applications: | 339 |
Formulation / Manufacturing: | see details |
Drug Sales Revenues: | Drug sales revenues for CRYSELLE |
DailyMed Link: | CRYSELLE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for CRYSELLE
US Patents and Regulatory Information for CRYSELLE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Duramed Pharms Barr | CRYSELLE | ethinyl estradiol; norgestrel | TABLET;ORAL-21 | 075840-001 | Nov 30, 2001 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Duramed Pharms Barr | CRYSELLE | ethinyl estradiol; norgestrel | TABLET;ORAL-28 | 075840-002 | Nov 30, 2001 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |